Related references
Note: Only part of the references are listed.
Article
Biochemistry & Molecular Biology
Lin Shi et al.
Summary: The study revealed that circSEC24A plays a negative role in OA, exacerbating IL-1 beta-induced injury by modulating the miR-142-5p/SOX5 axis.
BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY
(2022)
Article
Pathology
Alexandra Couto Oliveira et al.
Summary: The genomic complexity of multiple myeloma is reflected in the variable clinical presentation of patients, making genome-wide studies a reasonable alternative for identifying critical genomic lesions. The most frequently detected alterations in a Portuguese cohort of multiple myeloma patients were identified, with some having known prognostic value while others remain with unknown but potentially significant implications for clinical practice. Further assessment of these genomic alterations as possible biomarkers is warranted.
JOURNAL OF CLINICAL PATHOLOGY
(2022)
Article
Biochemistry & Molecular Biology
Fang Liu et al.
Summary: The study found that circ_0000142 is highly expressed in multiple myeloma patients and is significantly associated with disease staging and phase. circ_0000142 enhances the growth and metastasis of multiple myeloma cells by modulating the miR-610/AKT3 axis.
JOURNAL OF BIOCHEMISTRY
(2021)
Article
Cell Biology
Shanshan Yu et al.
Summary: This study identified a MM-associated circRNA, circ-MYBL2, which was significantly decreased in MM tissue and serum samples and correlated with high clinical stage and unfavorable prognosis. Circ-MYBL2 inhibited tumor growth by affecting the phosphorylation level of its linear isoform, suggesting a potential diagnostic, prognostic, and therapeutic target for MM patients.
Article
Hematology
Hira S. Mian et al.
Summary: Renal failure occurred in up to 22% of patients with multiple myeloma treated with Carfilzomib, with increasing age, pre-existing heart failure, and chronic kidney disease as risk factors. Further studies are needed to understand the exact cause and develop strategies to mitigate the risk.
ANNALS OF HEMATOLOGY
(2021)
Review
Medicine, General & Internal
Liliana Belgioia et al.
Summary: Multiple myeloma is an incurable malignant tumor mostly treated with chemotherapy, but radiotherapy can play a supportive or radical role for symptom relief and localized disease. Imaging is crucial for treatment planning and patient classification in both scenarios.
MEDICINA-LITHUANIA
(2021)
Review
Biochemistry & Molecular Biology
Xiaozhu Tang et al.
Summary: circRNAs are a class of interesting and conserved single-stranded RNA molecules that play important roles in various biological processes, especially in microRNA sponges, gene splicing and transcription regulation, RNA-binding protein sponges, and protein/peptide translation. They are involved in various human diseases, particularly cancers, and may serve as better predictive biomarkers and therapeutic targets for cancer treatment.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL
(2021)
Article
Biology
Lei Bi et al.
Summary: The study revealed that circ-HIPK3 plays a role in oral squamous cell carcinoma by regulating YAP1 expression through sponging miR-381-3p, affecting cell proliferation, invasion, migration, apoptosis, and tumor growth.
JOURNAL OF BIOSCIENCES
(2021)
Article
Biochemistry & Molecular Biology
Peng Shen et al.
Summary: The study identified that circNEIL3 is upregulated in PDAC and promotes tumor growth and metastasis by regulating the expression of ADAR1 through sponging miR-432-5p, ultimately affecting cell cycle progression and promoting EMT. The circNEIL3/miR-432-5p/ADAR1/GLI1/cell cycle and EMT axis is correlated with the clinical stage and overall survival of PDAC patients.
Article
Genetics & Heredity
Wenhui Huang et al.
Summary: The study found that IFI16 expression increased with multiple myeloma progression and was closely associated with disease advancement, 1q21 amplification, and relapse. High IFI16 expression was correlated with shorter survival and was identified as an independent poor prognostic factor for event-free survival (EFS) and overall survival (OS).
PHARMACOGENOMICS JOURNAL
(2021)
Article
Pharmacology & Pharmacy
Ruoyu Liu et al.
Summary: Plasma circular RNA hsa_circ_0005397 is upregulated in HCC patients and closely correlated with tumor size and TNM staging. Its combination with other biomarkers can improve diagnostic sensitivity for HCC, predict recurrence or metastasis, and is associated with shorter overall survival in HCC patients.
FRONTIERS IN PHARMACOLOGY
(2021)
Review
Immunology
Xingyu Zhai et al.
Summary: Circular RNAs (circRNAs) are abundant, stable RNA molecules with circular structures that can serve as biomarkers for various diseases. In the context of autoimmune diseases (AIDs), circRNAs offer new possibilities for diagnosis and treatment by impacting the pathophysiological processes.
FRONTIERS IN IMMUNOLOGY
(2021)
Article
Clinical Neurology
Qing Huang et al.
Summary: This study identified smoking, hair dyeing, prolonged sitting time, single animal oil intake, and hypertension as major risk factors for intracranial aneurysm rupture, while higher education levels, longer sleep durations, tea drinking, diabetes, and higher levels of certain biochemical markers were associated with a lower risk. The circular RNAs hsa_circ_0008433 and hsa_circ_0001946 were found to be closely related to intracranial aneurysm rupture and have good clinical diagnostic value. There was a multiplicative interaction between these circular RNAs and age in affecting the risk of intracranial aneurysm rupture.
FRONTIERS IN NEUROLOGY
(2021)
Article
Oncology
Huapeng Lin et al.
Summary: A novel prognostic model based on RSF was developed and validated to predict the survival of patients with BCLC stage B HCC, showing better performance than previous Cox proportional hazards models. The model identified five strong predictors of survival and had a c-index of 0.69 and AUROC values of 0.72, 0.71, and 0.73 for predicting survival outcomes within the first three years.
FRONTIERS IN ONCOLOGY
(2021)
Article
Biochemistry & Molecular Biology
Weijie Wang et al.
Summary: The study demonstrated that circ_0002346 was downregulated in NSCLC tissues and cell lines, and its overexpression inhibited the malignant properties of NSCLC cells by inducing apoptosis and suppressing proliferation, migration, invasion, and glycolysis. Furthermore, circ_0002346 acted as a sponge for miR-582-3p to upregulate the expression of STXBP6, leading to tumor suppression both in vitro and in vivo.
INTERNATIONAL JOURNAL OF GENOMICS
(2021)
Article
Oncology
Youn-Jung Kim et al.
Summary: This study analyzed the characteristics and in-hospital mortality of adult cancer patients visiting emergency departments in South Korea. The findings revealed that over half of cancer patients were admitted to the hospital, with an overall mortality rate of 16.1%, with lung cancer and liver cancer showing the highest mortality rates.
Article
Oncology
Thomas G. Martin et al.
Summary: This study evaluated the safety and efficacy of Isa and K combination therapy in patients with RRMM. Despite heavily pretreated patients, 70% responded to the treatment, with a median progression-free survival of 10.1 months.
Article
Oncology
Yiwen Xia et al.
Summary: The study revealed that circFAM73A is upregulated in gastric cancer tissues and is associated with poor prognosis in patients. Upregulation of circFAM73A enhances cell proliferation, migration, cisplatin resistance, and CSC-like properties in gastric cancer. Mechanistically, circFAM73A promotes gastric cancer malignancy through the miR-490-3p/HMGA2 positive feedback loop and recruitment of HNRNPK.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
(2021)
Article
Cell Biology
Chen Lu et al.
Summary: The study revealed that circETFA is overexpressed in HCC and associated with a poor prognosis, promoting the malignant progression of HCC through various mechanisms. It has the potential to serve as a novel biomarker and therapeutic target for HCC.
CELL DEATH DISCOVERY
(2021)
Article
Cell Biology
Ping Wu et al.
Summary: This study found that circRNA circCUX1 is upregulated in patients with HPSCC, mediates radiotherapy resistance through m6A methylation, and affects radiotherapy efficacy by inhibiting the release of inflammatory factors.
CELL DEATH & DISEASE
(2021)
Article
Multidisciplinary Sciences
Xuping Wu et al.
Summary: Thioredoxin reductase (TrxR) as a core tumor marker in liver cancer patients shows superior performance compared to AFP, CEA, and CA19-9. TrxR also demonstrates better effectiveness in evaluating chemotherapy outcomes. In chemotherapy-resistant patients and liver metastasis patients, TrxR exhibits higher activity levels than other general markers.
SCIENTIFIC REPORTS
(2021)
Article
Oncology
Fan Zhou et al.
Summary: Our study revealed that circ-PTK2 promotes cell proliferation and migration, while suppressing cell apoptosis in MM through miR-638 mediated MEK/ERK and WNT/β-catenin signaling pathways.
FRONTIERS IN ONCOLOGY
(2021)
Article
Biochemistry & Molecular Biology
Haipeng Jia et al.
Summary: This study showed that the expression of LBX2-AS1 was up-regulated in patients with multiple myeloma (MM) and positively correlated with LBX2 expression. Silencing LBX2-AS1 significantly weakened cell proliferation and induced apoptosis. Overexpressing LBX2-AS1 markedly increased LBX2 expression. Targeting LBX2-AS1 suppressed tumor progression by affecting the mRNA stability of LBX2 in MM.
FRONTIERS IN MOLECULAR BIOSCIENCES
(2021)
Review
Oncology
Jiaqi Wang et al.
Summary: Circular RNAs have been shown to play significant roles in drug-resistance activity in tumors, particularly in chemotherapy resistance. Further research is needed to explore the specific mechanisms by which circRNAs affect chemoresistance.
CANCER BIOLOGY & MEDICINE
(2021)
Article
Oncology
Megan S. Rice et al.
Summary: This study suggests that patients with asthma or COPD diagnosed in multiple myeloma (MM) may not experience shorter intervals to next treatment, but have significantly worse overall survival from the start of first-line therapy and numerically worse survival from the start of later lines. Larger datasets may help improve understanding of the impact of individual treatments on outcomes in these patients in the future.
ONCOLOGY AND THERAPY
(2021)
Article
Oncology
Youn-Jung Kim et al.
Summary: The study found that more than half of cancer patients visiting emergency departments were admitted to the hospital, with a mortality rate of 16.1%. Lung cancer, liver cancer, and leukemia/multiple myeloma had the highest mortality rates. Understanding the differences in prevalence and outcomes of oncological emergencies by cancer type is crucial for improving patient care.
Article
Medicine, Research & Experimental
Fang Chen et al.
EXPERIMENTAL BIOLOGY AND MEDICINE
(2020)
Article
Oncology
Xiao Liu et al.
CANCER MANAGEMENT AND RESEARCH
(2020)
Article
Immunology
Alessandra Zingoni et al.
FRONTIERS IN IMMUNOLOGY
(2018)
Review
Immunology
Niken M. Mahaweni et al.
FRONTIERS IN IMMUNOLOGY
(2018)
